SOURCE: BBK Worldwide

BBK Worldwide

June 15, 2016 09:00 ET

BBK Worldwide to Discuss mHealth and the Power of Improved Patient Engagement at the DIA 2016 Annual Meeting, June 26-30

BOSTON, MA--(Marketwired - June 15, 2016) - BBK Worldwide, an industry leader in patient recruitment and engagement technologies and services, will share key insights on mHealth and other patient engagement trends at the DIA 2016 52nd Annual Meeting, to be held at the Pennsylvania Convention Center in Philadelphia, June 26-30. The company will unveil and demo its comprehensive mobile app platform, which allows any clinical research or healthcare organization, including sponsors, CROs and advocacy groups, to utilize custom mobile apps in weeks instead of months, and at a small fraction of the cost of in-house development.

On Monday, June 27 at 4:30 p.m. EDT, BBK will host the Innovation Theater presentation "Reimagining the Patient Experience through mHealth Technologies." Newly appointed BBK President Matthew Kibby and Be the Partner CEO Thomas Klein will discuss the ways in which mHealth is facilitating new and improved engagement and communication between all study stakeholders, including patients, family caregivers, physicians, site staff and sponsors. New efforts to ensure that trial participants have access to study data and its collective impact on clinical research within new 21st century care models will be discussed.

Under the theme, "Enhancing the Patient Experience," the BBK booth will showcase its latest technologies through live demos, video and via Virtual Reality (VR) readers. Visit BBK booth #1610 to learn more about the company's mobile app platform and patient engagement solutions and consulting services for improved patient recruitment and retention. Members of the media and analyst communities interested in meeting with BBK executives at the show can contact Juli Greenwood at 617-515-8412 or

About BBK Worldwide
BBK Worldwide is the foremost patient recruitment and engagement technology firm, providing a range of award-winning creative services and technology solutions to the world's most innovative pharmaceutical and biopharmaceutical companies and their outsourced suppliers, such as CROs and eClinical providers. Committed to providing the support and solutions needed to improve patient engagement, enroll clinical studies on time, and expedite time-to-market, BBK delivers the industry's only suite of products built from the ground up to address the patient and site engagement challenges inherent in running large, multinational studies. Headquartered near Boston, Massachusetts, BBK has partners and offices across Europe and the Asia Pacific region. For more information, visit

Contact Information